SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-013913
Filing Date
2021-11-01
Accepted
2021-11-01 16:12:19
Documents
73
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crvs-20210930x10q.htm   iXBRL 10-Q 1993370
2 EX-10.1 crvs-20210930xex10d1.htm EX-10.1 78668
3 EX-10.2 crvs-20210930xex10d2.htm EX-10.2 35081
4 EX-31.1 crvs-20210930xex31d1.htm EX-31.1 11898
5 EX-31.2 crvs-20210930xex31d2.htm EX-31.2 11836
6 EX-32.1 crvs-20210930xex32d1.htm EX-32.1 11817
7 GRAPHIC crvs-20210930xex10d1001.jpg GRAPHIC 39256
8 GRAPHIC crvs-20210930xex10d2001.jpg GRAPHIC 4645
  Complete submission text file 0001558370-21-013913.txt   7165580

Data Files

Seq Description Document Type Size
9 EX-101.SCH crvs-20210930.xsd EX-101.SCH 44072
10 EX-101.CAL crvs-20210930_cal.xml EX-101.CAL 51588
11 EX-101.DEF crvs-20210930_def.xml EX-101.DEF 130496
12 EX-101.LAB crvs-20210930_lab.xml EX-101.LAB 408056
13 EX-101.PRE crvs-20210930_pre.xml EX-101.PRE 290320
14 EXTRACTED XBRL INSTANCE DOCUMENT crvs-20210930x10q_htm.xml XML 1220543
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37719 | Film No.: 211367278
SIC: 2834 Pharmaceutical Preparations